Precision medicine in 2026: from genes to clinical decisions
Understand how genomics, multiomics, AI, and digital biomarkers are moving healthcare decisions from averages to individualization.
Hub Page
From reactive treatment to proactive risk management
This cluster focuses on biomarkers, private blood tests, methylation testing, multi-omics, genetic screening, and longevity clinics. Moving from average statistics to individual baseline values.
Why this cluster matters
Precision medicine combines what makes the longevity market unique: data intensity, a high trust barrier, and a large difference between valid clinical signals and marketed complexity.
That is precisely why the site should have a clear hub here. The user must be able to move from an introduction to decision-oriented articles about clinics, biomarkers, and responsible interpretation.
Evidence and clinical perspectives
Precision medicine represents a paradigm shift from the traditional reactive healthcare system to a proactive, tailored model. Instead of treating diseases based on average guidelines, precision medicine uses detailed data from the individual. This includes genetic screening, epigenetic clocks, and advanced multi-omics analyses that map everything from your DNA to proteins and metabolites in the blood.
By combining this information with artificial intelligence, personal risk factors can be identified decades before a disease manifests. For longevity-oriented individuals, this opens up precise adjustments of preventive interventions, whether it concerns specific supplements, biomarker optimization, or targeted screening. We have gathered evidence-based knowledge to help you navigate genetics and make informed choices.
Articles in this cluster
21 articles in this hub
The hub page serves as an internal link node and aggregates the most important articles within the same topic.
Multiomics in 2026: what can genomics and epigenomics show?
Genomics, epigenomics, proteomics and metabolomics provide a more nuanced picture of biological age. See what they measure and when multiple layers help.
HBOT at home: what will pressure, safety and ISO mean in 2026?
Home HBOT chambers cost DKK 5,000-80,000 and vary in pressure and safety. See what ISO certification and oxygen concentration mean before buying.
HBOT at home vs clinic: what do you pay for and who are the two tracks suitable for?
Home HBOT provides flexibility but lower pressure. Clinic provides medical control. See what separates the two tracks in terms of price, safety and evidence.
Genetic screening in 2026: what can you use it for?
Genetic screening is gaining ground in precision medicine, but not all tests are equally useful. Understand the difference between benefit, risk and realistic expectations.
Private blood tests: which panels are worth buying?
Many blood test panels promise precision and control. Learn which measurements typically change a decision and which you can safely omit.
How to read your blood test results: a practical guide to numbers, cut-offs and the right questions
HbA1c, lipids, liver and kidney numbers, CRP, iron status — understand what your blood test results actually mean, what reference numbers cover and when to act.
Methylation tests vs blood tests: which measurement makes better decisions?
Methylation tests measure biological age. Classic blood tests measure clinical risk. Understand what is actionable now and what is still primarily research.
Biological age test in Denmark (2026): Which test is best and how much do they cost?
Comparison of biological age tests in Denmark in 2026: Bevivo, Nordic Medicine, Ætas and suPAR. We decode epigenetic clock, prices and data for the money.
Biomarkers you can act on: which ones are moving?
Biomarkers only provide value when they change a decision. See which measurements provide a real next step and what you can safely deviate from.
Neko Health scan: what can a full-body scan show?
Full-body scanning can find something important early, but also provide false reassurance. See what Neko measures, what it costs and who it's suitable for.
GI Genius and AI in the clinic: what do the algorithms find?
GI Genius uses AI for real-time polyp detection during colonoscopy. See what the algorithm finds, what it misses, and what it means for preventive medicine.
Longevity risk insurance: why is the financial world starting to take an interest in healthy ageing?
Longevity risk is the risk of surviving your savings. Understand what the term means for pension, healthspan and individual financial planning.
Longevity clinics: what to ask before you say yes?
The market for longevity clinics is growing, but the quality varies. See the specific questions you should ask, and the answers that reveal whether the clinic is serious.
DIY biology and nutrigenomics: what is actually useful and what is just biohacking romance?
DIY biology and nutrigenomics promise personal control over health. See what you can actually use in practice, and where the hype runs ahead of the evidence.
Metformin and aging: what does the research say about use in the healthy in 2026?
What does the research say about metformin and aging in healthy individuals? Read a detailed, evidence-based guide on clinical trials.
Testosterone after 50: when should you be tested and what do the numbers mean?
A practical Danish guide to testosterone and men's hormonal ageing: which symptoms are real, which tests make sense, what does the evidence say about TRT, and what can you do yourself for medical treatment?
Biological age testing in 2026: is an epigenetic test worth taking?
DunedinPACE and Horvath estimate biological age via methylation. Understand what they measure and when a test provides better decisions than more expensive data.
Biological Age (2026): What is it, how is it measured, and can you lower it?
What is your biological age? A scientific guide to how biological age is measured in 2026, the difference between epigenetic tests and telomeres, and how you can documentedly lower it.
CGM without diabetes for 14 days: what you can realistically learn and what is just noise
14-day guide to CGM without diabetes: what people typically see, how stress and late meals shift the curve, and what you can't conclude on your own.
Genetic tests — what can they actually tell you and what is pure hype?
Genetic tests promise insight into health, aging and disease risk. Learn what they can actually tell you and what is still consumer hype.